Please visit the contents of our website >
San Diego, CA, August 1, 2013 — Freedom Meditech today announced that it has closed a $7 million Series B financing. Funds will support the U.S. commercial launch of the ClearPath DS-120™ Lens Fluorescence Biomicroscope which was cleared by the U.S. Food and Drug Administration (FDA) earlier this year.
© 2011-2013 Freedom Meditech. All rights reserved.
| Terms & Conditions
| Accessibility Statement
| Site Map
| Contact Us